Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Underst…

Jaime Seltzer

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

GRACE

A. Goodman, A. Jeong, S. Rajeeve

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

CAR T-Cell Therapy in Autoimmune Disorders

Vanderbilt University Medical Center (VUMC)

O. Oluwole

CAR T-Cell Therapy Side Effects for Blood Cancers

GRACE

A. Goodman

CAR NK Cells: Next Generation Cell Therapies for Cancer

University of Colorado Cancer Center

K. Rezvani

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

The Improbable History of CAR T-Cells

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

C. June

Interventional Delivery of CAR-T Therapy

Michael Soulen

What's Hot (Not) in (HIV) Primary Care

UCSF School of Medicine

C. Bositis, J. Bloome

Bispecific vs. Combination Therapy - PRO Combination Therapy

ImmunoTherapy Bridge 2023

A. Patnaik

CAR T-Cell Failure: Mechanisms and Salvage Options

Beth Israel Deaconess Medical Center

J. Arnason

Bispecific vs. Combination Therapy - PRO Bispecific

ImmunoTherapy Bridge 2023

J. Gulley

Treatment of Symptomatic Brain Metastases in Melanoma: Combination o…

Melanoma Bridge 2023

H. Tawbi

Innovating Immunotherapy for Pancreatic Cancer

ImmunoTherapy Bridge 2023

G. Lesinski

Bispecific Antibodies and CAR T-Cells for NHL: Challenges and Opport…

Total Health

K. Komanduri

CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities

UNC Lineberger Comprehensive Cancer Center

M. Mcelfresh

New and Evolving Clinical Trials: Embolotherapy

SIR 2022 Coverage

M. Soulen